Back to Results
First PageMeta Content
Pharmaceutical industry / Chemistry / Pharmacology / Design of experiments / Epidemiology / Clinical trial / Adverse event / HIV / Canadian Institutes of Health Research / Research / Clinical research / Pharmaceutical sciences


CTN_Protocol_Template_V2-02
Add to Reading List

Document Date: 2010-04-20 21:05:09


Open Document

File Size: 420,34 KB

Share Result on Facebook

City

HELSINKI / /

Company

Immunodeficiency Syndrome AIDS / Drug Reaction Adverse Event/Adverse Experience / Safety Monitoring Board Food / US National Institutes of Health Data / Abbreviations (sample) ADR AE / Central Laboratory / /

Event

M&A / FDA Phase / /

Facility

LABORATORY EVALUATIONS AND SPECIMEN COLLECTION / /

IndustryTerm

thorough protocols / study protocols / /

MedicalCondition

HIV / Acquired Immunodeficiency Syndrome / AIDS / /

MedicalTreatment

CONTRACEPTION / NATURAL REMEDIES / /

Organization

World Health Organization / RESEARCH ETHICS BOARD/INSTITUTIONAL REVIEW BOARD / Food and Drug Administration / CTN National Centre / Research Organization / DJARS Committee / FDA / US Department of Health and Human Services Good Clinical Practice Human Immunodeficiency Virus / /

Person

QC SAE SMC SOP TPD / Deborah Kraus / /

/

Position

Investigator / Related Complex Clinical Investigator / Principal Investigator / / /

Product

Adverse Events Start Medication / CONCOMITANT ALCOHOL AND ILLICIT DRUG / STUDY MEDICATION / Treatment Complete Physical Exam Bloodwork Urine Test Start Medication / New Drug / /

PublishedMedium

BASELINE / /

Technology

Pharmacokinetics / physical exam Bloodwork Urine Test Adverse Events Concomitant meds Start Medication Protocol / HIV Trials Network Protocol / developing study protocols / 7 PROTOCOL / 30 30 PROTOCOL / 34 Protocol / /

SocialTag